Effects of cilostazol against the progression of carotid IMT in symptomatic ischemic stroke patients

Carotid intima-media thickness (IMT) is a surrogate marker for evaluating atherosclerotic vascular diseases. The phosphodiesterase inhibitor cilostazol attenuates the increase in carotid IMT in diabetes patients. We studied whether cilostazol can reduce the progression of carotid IMT in symptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Sung Hyuk, Lee, Ji Sung, Kim, Beom Joon, Hwang, Kyoung Jin, Kim, Jun-Hyun, Chang, Dae-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535378/
https://www.ncbi.nlm.nih.gov/pubmed/22820682
http://dx.doi.org/10.1007/s00415-012-6599-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535378/
https://www.ncbi.nlm.nih.gov/pubmed/22820682
http://dx.doi.org/10.1007/s00415-012-6599-y

Ejemplares similares